Combined Modality Therapy of Esophageal Cancer

By Juergens Rosalyn A.   Forastiere Arlene  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 851-861

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

By Heath Elisabeth   Burtness Barbara   Kleinberg Lawrence   Salem Ronald   Yang Stephen   Heitmiller Richard   Canto Marcia   Knisely Jonathan   Topazian Mark   Montgomery Elizabeth   Tsottles Nancy   Pithavala Yazdi   Rohmiller Bridget   Collier Mary   Forastiere Arlene  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 135-140

Springer Publishing Company

Access to resources Recommend Favorite

Combined Modality Therapy of Localized Gastric and Esophageal Cancers

By Das Prajnan   Fukami Norio   Ajani Jaffer A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 4, 2006-04 ,pp. : 375-382

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pancreatic Adenocarcinoma

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 10, 2007-11 ,pp. : 998-998

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite